Structural Study of a Novel Inhibitor with Bulky P1 Side Chain in Complex with Plasmepsin II -Implications for Drug Design
Lindberg, J., Johansson, P.-O., Rosenquist, A., Kvarnstroem, I., Vrang, L., Samuelsson, B., Unge, T.To be published.
Experimental Data Snapshot
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
PLASMEPSIN 2 | 331 | Plasmodium falciparum | Mutation(s): 0 EC: 3.4.23.39 | ![]() | |
UniProt | |||||
Find proteins for P46925 (Plasmodium falciparum (isolate HB3)) Explore P46925 Go to UniProtKB: P46925 | |||||
Entity Groups | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P46925 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
TIT Query on TIT | C [auth A], D [auth B] | N-((3S,4S)-5-[(4-BROMOBENZYL)OXY]-3-HYDROXY-4-{[N-(PYRIDIN-2-YLCARBONYL)-L-VALYL]AMINO}PENTANOYL)-L-ALANYL-L-LEUCINAMIDE C32 H45 Br N6 O7 QXHNYZQKWOKULQ-QPGFMSSHSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 44.21 | α = 90 |
b = 77.614 | β = 90 |
c = 84.237 | γ = 90 |
Software Name | Purpose |
---|---|
REFMAC | refinement |